Open5.860 | Close5.560 |
Vol / Avg.39.189K / 65.705K | Mkt Cap127.763M |
Day Range5.535 - 6.120 | 52 Wk Range2.750 - 10.290 |
Longboard Pharmaceuticals Stock (NASDAQ: LBPH) stock price, news, charts, stock research, profile.
Open5.860 | Close5.560 |
Vol / Avg.39.189K / 65.705K | Mkt Cap127.763M |
Day Range5.535 - 6.120 | 52 Wk Range2.750 - 10.290 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.600 | -0.650 | -0.0500 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-22 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 16.00 |
2023-08-07 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
2023-07-11 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
2023-07-06 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 16.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
LBPH | Longboard Pharmaceuticals | 1.28% | 127.8M |
ZVRA | Zevra Therapeutics | -2.93% | 174.2M |
SCYX | SCYNEXIS | 2.17% | 87.4M |
AQST | Aquestive Therapeutics | -0.67% | 99.4M |
ESPR | Esperion Therapeutics | 3.34% | 105.9M |
You can purchase shares of Longboard Pharmaceuticals (NASDAQ: LBPH) through any online brokerage.
Other companies in Longboard Pharmaceuticals’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), SCYNEXIS (NASDAQ:SCYX), Aquestive Therapeutics (NASDAQ:AQST), Esperion Therapeutics (NASDAQ:ESPR) and Alimera Sciences (NASDAQ:ALIM).
The latest price target for Longboard Pharmaceuticals (NASDAQ: LBPH) was reported by Cantor Fitzgerald on Tuesday, August 22, 2023. The analyst firm set a price target for 16.00 expecting LBPH to rise to within 12 months (a possible 187.77% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Longboard Pharmaceuticals (NASDAQ: LBPH) is $5.56 last updated September 29, 2023 at 8:02 PM UTC.
There is no dividend information for Longboard Pharmaceuticals.
Longboard Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Longboard Pharmaceuticals.
Longboard Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Longboard Pharmaceuticals Stock (NASDAQ: LBPH) stock price, news, charts, stock research, profile.
Open5.860 | Close5.560 |
Vol / Avg.39.189K / 65.705K | Mkt Cap127.763M |
Day Range5.535 - 6.120 | 52 Wk Range2.750 - 10.290 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.600 | -0.650 | -0.0500 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-22 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 16.00 |
2023-08-07 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
2023-07-11 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
2023-07-06 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 16.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
LBPH | Longboard Pharmaceuticals | 1.28% | 127.8M |
ZVRA | Zevra Therapeutics | -2.93% | 174.2M |
SCYX | SCYNEXIS | 2.17% | 87.4M |
AQST | Aquestive Therapeutics | -0.67% | 99.4M |
ESPR | Esperion Therapeutics | 3.34% | 105.9M |
You can purchase shares of Longboard Pharmaceuticals (NASDAQ: LBPH) through any online brokerage.
Other companies in Longboard Pharmaceuticals’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), SCYNEXIS (NASDAQ:SCYX), Aquestive Therapeutics (NASDAQ:AQST), Esperion Therapeutics (NASDAQ:ESPR) and Alimera Sciences (NASDAQ:ALIM).
The latest price target for Longboard Pharmaceuticals (NASDAQ: LBPH) was reported by Cantor Fitzgerald on Tuesday, August 22, 2023. The analyst firm set a price target for 16.00 expecting LBPH to rise to within 12 months (a possible 187.77% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Longboard Pharmaceuticals (NASDAQ: LBPH) is $5.56 last updated September 29, 2023 at 8:02 PM UTC.
There is no dividend information for Longboard Pharmaceuticals.
Longboard Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Longboard Pharmaceuticals.
Longboard Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Longboard Pharmaceuticals Stock (NASDAQ: LBPH) stock price, news, charts, stock research, profile.
Open5.860 | Close5.560 |
Vol / Avg.39.189K / 65.705K | Mkt Cap127.763M |
Day Range5.535 - 6.120 | 52 Wk Range2.750 - 10.290 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.600 | -0.650 | -0.0500 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-22 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 16.00 |
2023-08-07 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
2023-07-11 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
2023-07-06 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 16.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
LBPH | Longboard Pharmaceuticals | 1.28% | 127.8M |
ZVRA | Zevra Therapeutics | -2.93% | 174.2M |
SCYX | SCYNEXIS | 2.17% | 87.4M |
AQST | Aquestive Therapeutics | -0.67% | 99.4M |
ESPR | Esperion Therapeutics | 3.34% | 105.9M |
You can purchase shares of Longboard Pharmaceuticals (NASDAQ: LBPH) through any online brokerage.
Other companies in Longboard Pharmaceuticals’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), SCYNEXIS (NASDAQ:SCYX), Aquestive Therapeutics (NASDAQ:AQST), Esperion Therapeutics (NASDAQ:ESPR) and Alimera Sciences (NASDAQ:ALIM).
The latest price target for Longboard Pharmaceuticals (NASDAQ: LBPH) was reported by Cantor Fitzgerald on Tuesday, August 22, 2023. The analyst firm set a price target for 16.00 expecting LBPH to rise to within 12 months (a possible 187.77% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Longboard Pharmaceuticals (NASDAQ: LBPH) is $5.56 last updated September 29, 2023 at 8:02 PM UTC.
There is no dividend information for Longboard Pharmaceuticals.
Longboard Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Longboard Pharmaceuticals.
Longboard Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Longboard Pharmaceuticals Stock (NASDAQ: LBPH) stock price, news, charts, stock research, profile.
Open5.860 | Close5.560 |
Vol / Avg.39.189K / 65.705K | Mkt Cap127.763M |
Day Range5.535 - 6.120 | 52 Wk Range2.750 - 10.290 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.600 | -0.650 | -0.0500 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-22 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 16.00 |
2023-08-07 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
2023-07-11 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
2023-07-06 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 16.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
LBPH | Longboard Pharmaceuticals | 1.28% | 127.8M |
ZVRA | Zevra Therapeutics | -2.93% | 174.2M |
SCYX | SCYNEXIS | 2.17% | 87.4M |
AQST | Aquestive Therapeutics | -0.67% | 99.4M |
ESPR | Esperion Therapeutics | 3.34% | 105.9M |
You can purchase shares of Longboard Pharmaceuticals (NASDAQ: LBPH) through any online brokerage.
Other companies in Longboard Pharmaceuticals’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), SCYNEXIS (NASDAQ:SCYX), Aquestive Therapeutics (NASDAQ:AQST), Esperion Therapeutics (NASDAQ:ESPR) and Alimera Sciences (NASDAQ:ALIM).
The latest price target for Longboard Pharmaceuticals (NASDAQ: LBPH) was reported by Cantor Fitzgerald on Tuesday, August 22, 2023. The analyst firm set a price target for 16.00 expecting LBPH to rise to within 12 months (a possible 187.77% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Longboard Pharmaceuticals (NASDAQ: LBPH) is $5.56 last updated September 29, 2023 at 8:02 PM UTC.
There is no dividend information for Longboard Pharmaceuticals.
Longboard Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Longboard Pharmaceuticals.
Longboard Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Longboard Pharmaceuticals Stock (NASDAQ: LBPH) stock price, news, charts, stock research, profile.
Open5.860 | Close5.560 |
Vol / Avg.39.189K / 65.705K | Mkt Cap127.763M |
Day Range5.535 - 6.120 | 52 Wk Range2.750 - 10.290 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.600 | -0.650 | -0.0500 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-22 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 16.00 |
2023-08-07 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
2023-07-11 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
2023-07-06 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 16.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
LBPH | Longboard Pharmaceuticals | 1.28% | 127.8M |
ZVRA | Zevra Therapeutics | -2.93% | 174.2M |
SCYX | SCYNEXIS | 2.17% | 87.4M |
AQST | Aquestive Therapeutics | -0.67% | 99.4M |
ESPR | Esperion Therapeutics | 3.34% | 105.9M |
You can purchase shares of Longboard Pharmaceuticals (NASDAQ: LBPH) through any online brokerage.
Other companies in Longboard Pharmaceuticals’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), SCYNEXIS (NASDAQ:SCYX), Aquestive Therapeutics (NASDAQ:AQST), Esperion Therapeutics (NASDAQ:ESPR) and Alimera Sciences (NASDAQ:ALIM).
The latest price target for Longboard Pharmaceuticals (NASDAQ: LBPH) was reported by Cantor Fitzgerald on Tuesday, August 22, 2023. The analyst firm set a price target for 16.00 expecting LBPH to rise to within 12 months (a possible 187.77% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Longboard Pharmaceuticals (NASDAQ: LBPH) is $5.56 last updated September 29, 2023 at 8:02 PM UTC.
There is no dividend information for Longboard Pharmaceuticals.
Longboard Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Longboard Pharmaceuticals.
Longboard Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Longboard Pharmaceuticals Stock (NASDAQ: LBPH) stock price, news, charts, stock research, profile.
Open5.860 | Close5.560 |
Vol / Avg.39.189K / 65.705K | Mkt Cap127.763M |
Day Range5.535 - 6.120 | 52 Wk Range2.750 - 10.290 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.600 | -0.650 | -0.0500 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-22 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 16.00 |
2023-08-07 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
2023-07-11 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
2023-07-06 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 16.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
LBPH | Longboard Pharmaceuticals | 1.28% | 127.8M |
ZVRA | Zevra Therapeutics | -2.93% | 174.2M |
SCYX | SCYNEXIS | 2.17% | 87.4M |
AQST | Aquestive Therapeutics | -0.67% | 99.4M |
ESPR | Esperion Therapeutics | 3.34% | 105.9M |
You can purchase shares of Longboard Pharmaceuticals (NASDAQ: LBPH) through any online brokerage.
Other companies in Longboard Pharmaceuticals’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), SCYNEXIS (NASDAQ:SCYX), Aquestive Therapeutics (NASDAQ:AQST), Esperion Therapeutics (NASDAQ:ESPR) and Alimera Sciences (NASDAQ:ALIM).
The latest price target for Longboard Pharmaceuticals (NASDAQ: LBPH) was reported by Cantor Fitzgerald on Tuesday, August 22, 2023. The analyst firm set a price target for 16.00 expecting LBPH to rise to within 12 months (a possible 187.77% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Longboard Pharmaceuticals (NASDAQ: LBPH) is $5.56 last updated September 29, 2023 at 8:02 PM UTC.
There is no dividend information for Longboard Pharmaceuticals.
Longboard Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Longboard Pharmaceuticals.
Longboard Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Longboard Pharmaceuticals Stock (NASDAQ: LBPH) stock price, news, charts, stock research, profile.
Open5.860 | Close5.560 |
Vol / Avg.39.189K / 65.705K | Mkt Cap127.763M |
Day Range5.535 - 6.120 | 52 Wk Range2.750 - 10.290 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.600 | -0.650 | -0.0500 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-22 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 16.00 |
2023-08-07 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
2023-07-11 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
2023-07-06 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 16.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
LBPH | Longboard Pharmaceuticals | 1.28% | 127.8M |
ZVRA | Zevra Therapeutics | -2.93% | 174.2M |
SCYX | SCYNEXIS | 2.17% | 87.4M |
AQST | Aquestive Therapeutics | -0.67% | 99.4M |
ESPR | Esperion Therapeutics | 3.34% | 105.9M |
You can purchase shares of Longboard Pharmaceuticals (NASDAQ: LBPH) through any online brokerage.
Other companies in Longboard Pharmaceuticals’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), SCYNEXIS (NASDAQ:SCYX), Aquestive Therapeutics (NASDAQ:AQST), Esperion Therapeutics (NASDAQ:ESPR) and Alimera Sciences (NASDAQ:ALIM).
The latest price target for Longboard Pharmaceuticals (NASDAQ: LBPH) was reported by Cantor Fitzgerald on Tuesday, August 22, 2023. The analyst firm set a price target for 16.00 expecting LBPH to rise to within 12 months (a possible 187.77% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Longboard Pharmaceuticals (NASDAQ: LBPH) is $5.56 last updated September 29, 2023 at 8:02 PM UTC.
There is no dividend information for Longboard Pharmaceuticals.
Longboard Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Longboard Pharmaceuticals.
Longboard Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Longboard Pharmaceuticals Stock (NASDAQ: LBPH) stock price, news, charts, stock research, profile.
Open5.860 | Close5.560 |
Vol / Avg.39.189K / 65.705K | Mkt Cap127.763M |
Day Range5.535 - 6.120 | 52 Wk Range2.750 - 10.290 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.600 | -0.650 | -0.0500 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-22 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 16.00 |
2023-08-07 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
2023-07-11 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
2023-07-06 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 16.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
LBPH | Longboard Pharmaceuticals | 1.28% | 127.8M |
ZVRA | Zevra Therapeutics | -2.93% | 174.2M |
SCYX | SCYNEXIS | 2.17% | 87.4M |
AQST | Aquestive Therapeutics | -0.67% | 99.4M |
ESPR | Esperion Therapeutics | 3.34% | 105.9M |
You can purchase shares of Longboard Pharmaceuticals (NASDAQ: LBPH) through any online brokerage.
Other companies in Longboard Pharmaceuticals’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), SCYNEXIS (NASDAQ:SCYX), Aquestive Therapeutics (NASDAQ:AQST), Esperion Therapeutics (NASDAQ:ESPR) and Alimera Sciences (NASDAQ:ALIM).
The latest price target for Longboard Pharmaceuticals (NASDAQ: LBPH) was reported by Cantor Fitzgerald on Tuesday, August 22, 2023. The analyst firm set a price target for 16.00 expecting LBPH to rise to within 12 months (a possible 187.77% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Longboard Pharmaceuticals (NASDAQ: LBPH) is $5.56 last updated September 29, 2023 at 8:02 PM UTC.
There is no dividend information for Longboard Pharmaceuticals.
Longboard Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Longboard Pharmaceuticals.
Longboard Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Longboard Pharmaceuticals Stock (NASDAQ: LBPH) stock price, news, charts, stock research, profile.
Open5.860 | Close5.560 |
Vol / Avg.39.189K / 65.705K | Mkt Cap127.763M |
Day Range5.535 - 6.120 | 52 Wk Range2.750 - 10.290 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.600 | -0.650 | -0.0500 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-22 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 16.00 |
2023-08-07 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
2023-07-11 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
2023-07-06 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 16.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
LBPH | Longboard Pharmaceuticals | 1.28% | 127.8M |
ZVRA | Zevra Therapeutics | -2.93% | 174.2M |
SCYX | SCYNEXIS | 2.17% | 87.4M |
AQST | Aquestive Therapeutics | -0.67% | 99.4M |
ESPR | Esperion Therapeutics | 3.34% | 105.9M |
You can purchase shares of Longboard Pharmaceuticals (NASDAQ: LBPH) through any online brokerage.
Other companies in Longboard Pharmaceuticals’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), SCYNEXIS (NASDAQ:SCYX), Aquestive Therapeutics (NASDAQ:AQST), Esperion Therapeutics (NASDAQ:ESPR) and Alimera Sciences (NASDAQ:ALIM).
The latest price target for Longboard Pharmaceuticals (NASDAQ: LBPH) was reported by Cantor Fitzgerald on Tuesday, August 22, 2023. The analyst firm set a price target for 16.00 expecting LBPH to rise to within 12 months (a possible 187.77% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Longboard Pharmaceuticals (NASDAQ: LBPH) is $5.56 last updated September 29, 2023 at 8:02 PM UTC.
There is no dividend information for Longboard Pharmaceuticals.
Longboard Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Longboard Pharmaceuticals.
Longboard Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.